Published on : Feb 23, 2018
The Centers for Disease Control and Prevention (CDC) has recommended consumers to entirely avoid the use of herbal supplement kratom, which originates from Southeast Asia. On Tuesday, the Food and Drug Administration (FDA) had publicized in a press release that it has been looking at a rising count of reports of deleterious events and peer-reviewed research associated with the use of the supplement, which include 44 reported death cases. The FDA has also announced about its concerns regarding risks related to the use in the release. Although the CDC has recommended against using the supplement, it has not yet determined the contaminated source of the supplement.
Significant Safety Issues Exist, Reads Statement by FDA Commissioner
The CDC has announced that across 20 U.S. states, including 11 reported hospitalizations, there had been 28 cases of salmonella already reported. Out of the 11 affected people interviewed by the CDC so far, eight have reported of having taken kratom just before falling sick. Symptoms such as diarrhea, abdominal pain, and fever were commonly observed in these cases. The FDA has said that it is ready to take up the challenge of evaluating evidence that could demonstrate the supplement’s medicinal purpose. However, it has not yet received any such submissions neither any evidence has come to its knowledge that would meet its approval standard.
However, evidence regarding the presence of opioid compounds in kratom had been cited earlier in February in a statement issued by the FDA’s commissioner. The statement has said that the supplement lacks reliable evidence supporting its use in the treatment of opioid use disorder.